A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease

Tohoku Journal of Experimental Medicine

Volumn 209, Issue 3, 2006, Pages 181-189

  Shimizu, Yasuo ^a   Dobashi, Kunio ^b   Kobayashi, Setsuo ^c   Ohki, Ichiro ^c   Tokushima, Masahiko ^c   Kusano, Motoyasu ^a   Kawamura, Osamu ^a   Shimoyama, Yasuyuki ^a   Utsugi, Mitsuyoshi ^a   Sunaga, Noriaki ^a   Ishizuka, Tamotsu ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c Maebashi North Hospital   (Japan)

Author keywords

Asthma; Gastroesophageal reflux disease; H2 receptor blocker; Proton pump inhibitor

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; PROTON PUMP INHIBITOR; ROXATIDINE;

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFLAMMATION; SCORING SYSTEM; SYMPTOMATOLOGY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADULT; AGED; ASTHMA; DRUG EVALUATION; FEMALE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEAK EXPIRATORY FLOW RATE; PIPERIDINES; PROSPECTIVE STUDIES; PROTON PUMPS; QUESTIONNAIRES;

EID: 33745195995     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.209.181     Document Type: Article

References (37)

1. Altschuler, S.M. (2001) Laryngeal and respiratory protective reflexes. Am. J. Med., 111, 90S-94S.
2. American Thoracic Society (1962) Definition and classification of chronic bronchitis, asthma and pulmonary emphysema. Am. Rev. Respir. Dis., 85, 762-768.
3. Armstrong, D., Bennett, J.R., Blum, A.L., Dent, J., De Dombal, F.T., Galmiche, J.P., Lundell, L., Margulies, M., Richter, J.E., Spechler, S.J., Tygat, G.N. & Wallin, L. (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology, 111, 85-92.
4. Boeree, M.J., Peters, F.T., Postma, D.S. & Kleibeuker, J.H. (1998) No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a) symptomatic gastro-oesophageal reflux. Eur. Respir. J., 11, 1070-1074.
5. Canning, B. & Mazzone, S.B. (2003) Reflex mechanisms in gastroesophageal reflux disease and asthma. Am. J. Med., 115, 45S-48S.
6. Carlsson, R., Dent, J., Bolling-Sternevald, F., Johnsson, F., Johnsson, F., Junghard, O., Lauritsen, K., Riley, S. & Lundell, L. (1998) The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand. J. Gastroenterol., 33, 1023-1029.
7. Chiba, N. (1997) Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Can. J. Gastroenterol., 11, 66B-73B.
8. Ekstrom, T., Lindgren, B.R. & Tibbling, L. (1989) Effects of ranitidine treatment on patients with asthma and a history of gastro-oesophageal reflux: a double blind crossover study. Thorax, 44, 19-23.
9. Field, S.K. & Sutherland, L.R. (1998) Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature. Chest, 114, 275-283.
10. Ford, G.A., Oliver, P.S., Prior, J.S. & Butland, R.J. (1994) Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study. Postgrad Med. J., 70, 350-354.
11. Friedrich, P., Botzler, R., Mayershofer, R. & Kriech, W. (1996) Roxatidine acetate in therapy of reflux esophagitis. Fortschr. Med., 114, 213-216.
12. Goodall, R.J., Cooper, D.N., Bernstein, A. & Temple, J.G. (1981) Relationship between asthma and gastro-oesophageal reflux. Thorax, 36, 116-121.
13. Gustaffson, P.M., Kjellman, N.J. & Tibbling, L. (1992) A trial of ranitidine in asthmatic children and adolescents with or without pathological gastro-oesophageal reflux. Eur. Respir. J., 5, 201-206.
14. Harding, S.M., Richter, J.E., Guzzo, M.R & Schan, C.A. (1996) Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am. J. Med., 100, 395-405.
15. Harding, S.M. & Sontag, S.J. (2000) Asthma and gastroesophageal reflux. Am. J. Gastroenterol., 95, S23-S32.
16. Harmanci, E., Entok, E., Metintas, M. & Vardareli, E. (2001) Gastroesophageal reflux in the patients with asthma. Allergol. Immunopathol. (Madr)., 29, 123-128.
17. Harper, P.C., Bergner, A. & Kaye, M.D. (1987) Antireflux treatment for asthma. Improvement in patients with associated gastroesophageal reflux. Arch. Intern. Med., 147, 56-60.
18. Hatlebakk, J.G. & Berstad, A. (1996) Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Clin. Pharmacokinet., 31, 386-406.
19. Hongo, M., Kimpara, T., Moriyama, S., Ohara, S., Sone, S., Tamura, T., Asaki, S. & Toyota, T. (1998) Effect of rabeprazole (E3810), a novel proton pump inhibitor, on intragastric pH in healthy volunteers. Tohoku J. Exp. Med., 186, 43-50.
20. Hoshihara, Y. & Hashimoto, M. (2000) Endoscopic classification of reflux esophagitis. Nippon Rinsho., 58, 1808-1812.
21. Juniper, E.F., O'Byrne, P.M., Guyatt, G.H. & Ferrie, P.J. (1999) Development and validation of a questionnaire to measure asthma control. Eur. Respir. J., 14, 902-907.
22. Kiljander, T.O. (2003) The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough. Am. J. Med., 115, 65S-71S.
23. Kiljander, T.O., Harding, S.M., Field, S.K., Stein, M.R., Nelson, H.S., Ekelund, J., Illueca, M., Beckman, O. & Sostek, M.B. (2006) Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am. J. Respir. Crit. Care Med., 173, 1091-1097.
24. Laheij, R.J., Sturkenboom, M.C., Hassing, R.J. & Dieleman, J. (2004) Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA, 292, 1955-1960.
25. Larrain, A., Carrascos, E., Galleguillos, F. & Sepulveda, R. (1991) Medical and surgical treatment of nonallergic asthma associated with gastroesophageal reflux. Chest, 99, 1330-1335.
26. Leggett, J.J., Johnston, B.T., Mills, M. & Gamble, J. (2005) Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest, 127, 1227-1231.
27. Malagelada, J.R. (2004) Supra-oesophageal manifestations of gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther., 19, 43-48.
28. Meier, J.H., McNally, P.R., Punja, M. & Freeman, S.R. (1994) Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig. Dis. Sci., 39, 2127-2133.
29. Nagel, R.A., Brown, P., Perks, W.H. & Wilson, R.S. (1988) Ambulatory pH monitoring of gastro-oesophageal reflux in "morning dipper" asthmatics. BMJ, 297, 1371-1373.
30. National Institute of Health, National Heart, Lung, and Blood institute (2003) Global strategy for asthma treatment and prevention, Global initiative for asthma® (GINA).
31. Ricciardolo, F.L., Gaston, B. & Hunt, J. (2004) Acid stress in the pathology of asthma. J. Allergy Clin. Immunol., 113, 610-619.
32. Rosenhall, L., Elvstrand, A., Tilling, B., Vinge, I., Jemsby, P., Stahl, E., Jerre, F. & Bergqvist, P.B. (2003) One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma. Respir. Med., 97, 702-708.
33. Shimoyama, Y., Kusano, M., Sugimoto, S., Kawamura, O., Maeda, M., Minashi, K., Kuribayashi, S., Higuchi, T., Zai, H., Ino, K., Horikoshi, T., Moki, F., Sugiyama, T., Toki, M., Ohwada, T. & Mori, M. (2005) Diagnosis of gastroesophageal reflux disease using a new questionnaire. J. Gastroenterol. Hepatol., 20, 643-647.
34. Teichtahl, H., Kronborg, I.J., Yeomans, N.D. & Robbinson, P. (1996) Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma. Aust. NZ J. Med., 26, 671-676.
35. Tsugeno, H., Mizuno, M., Fujiki, H., Okada, H., Okamoto, M., Hosaki, Y., Ashida, S., Mitsunobu, F., Tanizaki, Y. & Shiratori, Y. (2003) A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux. Scand. J. Gastroenterol., 38, 456-461.
36. Tuchman, D.N., Boyle, J.T., Pack, A.L., Scwartz, J., Kokonos, M., Spitzer, A.R. & Cohen, S. (1984) Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology, 87, 872-881.
37. Vollmer, W.M., Markson, L.E., O'conner, E., Sanocki, L.L., Fiterman, L., Berger, M. & Buist, A.S. (1999) Association of asthma control with health care utilization and quality of life. Am. J. Respir. Crit. Care Med., 160, 1647-1652.